Role of Serum Transferrin Receptor in Diagnosing and Differentiating Iron Deficiency Anemia from Anemia of Chronic Disease in Patients with Chronic Kidney Disease

Authors

  • Abdul Latif Registrar, Nephrology & Dialysis Unit-3, BIRDEM, Dhaka
  • Muhammad Rafiqul Alam Professor, Nephrology, BSMMU, Dhaka
  • Asia Khanam Professor of Nephrology, BSMMU, Dhaka
  • Farhana Hoque Associate Professor, Physiology, Kumudini Women?s Medical College, Mirzapur, Tangail
  • Muhammad Abdur Rahim Assistant Professor, Nephrology & Dialysis Unit-1, BIRDEM, Dhaka
  • Rafi Nazrul Islam Assistant Registrar, Nephrology & Dialysis Unit-2, BIRDEM, Dhaka

DOI:

https://doi.org/10.3329/birdem.v7i2.32451

Keywords:

Anemia, anemia of chronic disease, CKD, ferritin, iron deficiency anaemia, soluble transferrin receptor

Abstract

Background: Anemia is common in patients with chronic kidney disease (CKD) and this is generally anemia of chronic disease, but iron deficiency anemia (IDA) is also common. Soluble transferrin receptor (sTfR) is a useful marker for IDA. Present study was undertaken to assess the utility of sTfR as a marker of IDA in selected group of Bangladeshi patients with CKD.

Methods: This cross-sectional study was conducted in the Department of Nephrology, BSMMU, Dhaka, Bangladesh from January 2013 to December 2014. Patients with anemia admitted in nephrology department whether on hemodialysis or not and medicine department of BSMMU were taken for study. The study population was further divided into two groups; Group A, patients who are having IDA and Group B, patients with ACD and a control group was also selected. Data were collected by face to face interview and laboratory investigations with a self-administered questionnaire.

Results: The mean age of the patients in two study groups were 38.40±13.23 and 34.85±10.52 years respectively and male-female ratio were 0.5:1 and 1:0.5. Mean sTfR level was higher (4.81± 1.64 ?g/ml) in patients with IDA than (2.89±1.40 ?g/ml) in patients with ACD (p <0.0001). In our study mean ferritin level was 599.59± 449.15?g/L in ACD patients whereas 101.23±119.42 in IDA patients (p<0.0001). Total iron binding capacity (TIBC) was more in ACD patients with sTfRe3?g/ml as compared to ACD patients with sTfR<3?g/ml. Transferrin saturation (TSAT) level was significantly decreased in ACD patients with sTfR ?3?g/ml as compared to ACD patients with sTfR<3?g/ml.

Conclusion: sTfR has a comparable ability to S. ferritin in diagnosing IDA and ACD. However, sTfR and serum ferritin alone cannot definitely exclude co-existing iron deficiency in ACD. As sTfR is not affected by infection and/or inflammation, thus providing a non-invasive alternative to bone marrow study.

Birdem Med J 2017; 7(2): 132-137

Downloads

Download data is not yet available.
Abstract
692
PDF
1281

Author Biography

Abdul Latif, Registrar, Nephrology & Dialysis Unit-3, BIRDEM, Dhaka



Downloads

Published

2017-05-04

How to Cite

Latif, A., Alam, M. R., Khanam, A., Hoque, F., Rahim, M. A., & Islam, R. N. (2017). Role of Serum Transferrin Receptor in Diagnosing and Differentiating Iron Deficiency Anemia from Anemia of Chronic Disease in Patients with Chronic Kidney Disease. BIRDEM Medical Journal, 7(2), 132–137. https://doi.org/10.3329/birdem.v7i2.32451

Issue

Section

Original Articles